论文部分内容阅读
由中国药材公司主持的《新药审批办法》讨论会于7月11日～14日在北京召开。会上结合中药的特点,对卫生部制订的《新药审批办法》和《新药审批办法有关中药问题的补充规定和说明》两个文件进行了热烈地讨论。代表们根据实际情况认为《新药审批办法》和《审批细则》对中药新药审批要求比较严格。自从85年7月实施以来,全国通过审批的中药新药产品为数不多。根据大家所
The “Approval Measures for New Drugs” seminar hosted by China National Herbal Medicine Company was held in Beijing on July 11th to 14th. At the meeting, in conjunction with the characteristics of traditional Chinese medicine, the two documents of the “Approval Measures for New Drugs” and “Supplementary Provisions and Explanations on the Issues of Chinese Medicines for the New Drug Approval Methods” formulated by the Ministry of Health were discussed. According to the actual situation, the deputies considered that the “Approval Measures for New Drugs” and the “Details of the Approval Rules” have stricter requirements for the examination and approval of new Chinese medicines. Since the implementation in July of the year of July 85, there have been only a few Chinese medicines that have passed the examination and approval. According to everyone